Literature DB >> 34635976

Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit.

Sridevi Murali-Nanavati1, Nita S Nair2, Rajendra Badwe2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34635976     DOI： 10.1245/s10434-021-10887-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  2 in total

1.  Presence of a growth-stimulating factor in serum following primary tumor removal in mice.

Authors:  B Fisher; N Gunduz; J Coyle; C Rudock; E Saffer
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

2.  Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.

Authors:  V Bjelic-Radisic; F Fitzal; M Knauer; G Steger; D Egle; R Greil; P Schrenk; M Balic; Ch Singer; R Exner; L Soelkner; Michael Gnant
Journal:  BMC Cancer       Date:  2020-05-06       Impact factor: 4.430
  2 in total
  1 in total

1.  Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit: Author's Reply.

Authors:  Kelly Stahl; Daleela Dodge; Chan Shen
Journal:  Ann Surg Oncol       Date:  2021-10-18       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.